Cellular loss after allogenic hepatocyte transplantation

Transplantation
Bing HanBo Qu

Abstract

Hepatocyte transplantation (HCTx) has been considered as an alternative to orthotopic liver transplantation for the treatment of acute and chronic liver failure and metabolic liver diseases. One of the factors that mainly limit its application is the significant cellular loss after HCTx. Although liver has been considered as an immunologically privileged organ, transplanted hepatocytes can only survive for 7 to 10 days without immunosuppression. In fact, both innate and adaptive immune system are implicated in the destruction to allografts, which is a particular type of rejection. This article has reviewed the progress in the mechanisms of cellular loss after allogenic HCTx.

References

Aug 8, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G L BumgardnerW L Frankel
Oct 2, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G L BumgardnerC G Orosz
Jan 12, 1999·Transplantation·G L BumgardnerC G Orosz
Jan 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S GuptaP M Novikoff
Mar 26, 1999·European Journal of Immunology·T ChenS Kozlowski
May 12, 2000·Immunological Reviews·G L Bumgardner, C G Orosz
Aug 10, 2000·Immunological Reviews·L Lu, D G Osmond
Oct 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D GaoG L Bumgardner
Mar 27, 2001·Transplantation Proceedings·W L OlszewskiB Mecner
May 16, 2002·Transplantation Proceedings·W L OlszewskiB Mecner
Sep 27, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Yue WangGinny L Bumgardner
Oct 27, 2004·Transplantation·Keri E LunsfordGinny L Bumgardner
Mar 19, 2005·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Olivia M Martinez, Hugo R Rosen
Aug 27, 2005·Transplantation·Phillip H HorneGinny L Bumgardner
Dec 13, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Keri E LunsfordGinny L Bumgardner
Jul 11, 2006·Cell Transplantation·Stephen C StromToshio Miki
Aug 24, 2006·Transplantation·Robert A Fisher, Stephen C Strom
Jun 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Phillip H HorneGinny L Bumgardner

❮ Previous
Next ❯

Citations

Nov 16, 2011·Transplantation·Robin D HughesAnil Dhawan
Sep 7, 2013·Cirugía española·Eugenia ParejaJose Mir
Aug 8, 2015·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Anil Dhawan
Nov 26, 2009·Cytotherapy·Setara BegumSuchitra Sumitran-Holgersson
Dec 6, 2011·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Yue YuScott L Nyberg
Jun 29, 2010·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Benjamin M StutchfieldStephen J Wigmore
Sep 11, 2010·Stem Cell Research·Garrett R Roll, Holger Willenbring
Apr 10, 2012·Best Practice & Research. Clinical Gastroenterology·Francesco P Russo, Maurizio Parola
Mar 25, 2016·World Journal of Transplantation·Felix OldhaferFlorian W R Vondran
Dec 15, 2018·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Trinidad CisnerosOlivia M Martinez
Jul 29, 2016·Science Translational Medicine·Raymond D HickeyScott L Nyberg
May 8, 2018·Current Transplantation Reports·James E SquiresAlejandro Soto-Gutierrez
Jun 3, 2017·The International Journal of Artificial Organs·Elisa BelaschkMartina T Mogl
Jan 25, 2018·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Daphne E DeTempleFlorian W R Vondran
Mar 26, 2021·Seminars in Liver Disease·Sheeba KhanPhilip N Newsome
Nov 5, 2014·Cell Medicine·Yue YuScott L Nyberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Journal of Gastroenterology and Hepatology
Yock Young Dan, George C Yeoh
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
S GuptaJ R Chowdhury
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Snorri S Thorgeirsson, Joe W Grisham
© 2021 Meta ULC. All rights reserved